Skip to main content

Advertisement

SpringerLink
Log in

Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Periostin is over expressed in many epithelial malignant cancers, including lung cancer, breast cancer, ovarian cancer and colon cancer. It is related with the progression and migration of breast and ovarian cancer cells in vitro. The aim of this study was to investigate the serum level of periostin in non-small cell lung cancer (NSCLC) and its relationship with established biological and prognostic factors by enzyme-linked-immunosorbent serologic assay. We also observe the function of periostin on the proliferation and migration of human lung adenocarcinoma cell line (A549) and discuss the mechanism. The mean value for serum periostin (POSTN) was elevated in NSCLC patients (242.84 ± 5.33 pg/ml) compared to the normal healthy volunteers (215.66 ± 11.67 pg/ml) (p = 0.030). The serum level of periostin of NSCLC patients had no connection with gender, age, pathological type, TNM stage, lymph node status, tumor size and invasiveness. We constructed a plasmid named pEGFP-N1/POSTN expressing full-length human periostin. Transfecting the plasmid to A549 cells and periostin was efficiently expressed in transfected A549 cells. Our data showed that periostin could promote the proliferation and migration of A549 cells by inducing vimentin and N-cadherin expression and downregulating E-cadherin expression. These results strongly suggest that periostin is a novel molecular which play an important role during the progression and development of NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108. doi:10.3322/canjclin.55.2.74

    Article  PubMed  Google Scholar 

  2. Takeshita S, Kikuno R, Tezuka K, Amann E (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294:271–278

    CAS  PubMed  Google Scholar 

  3. Kruzynska-Frejtag A, Wang J, Maeda M, Rogers R, Krug E, Hoffman S et al (2004) Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn 229:857–868. doi:10.1002/dvdy.10453

    Article  CAS  PubMed  Google Scholar 

  4. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T (2007) Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 22:1167–1174

    CAS  PubMed  Google Scholar 

  5. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD (2002) Periostin secreted by epithelial ovarian carcinoma is a ligand for αVβ3 and αVβ5 integrins and promotes cell motility. Cancer Res 62:5358–5364

    CAS  PubMed  Google Scholar 

  6. Tai IT, Dai M, Chen LB (2005) Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis 26:908–915. doi:10.1093/carcin/bgi034

    Article  CAS  PubMed  Google Scholar 

  7. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H et al (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β. J Bone Miner Res 14:1239–1249. doi:10.1359/jbmr.1999.14.7.1239

    Article  CAS  PubMed  Google Scholar 

  8. Ji X, Chen D, Xu C, Harris SE, Mundy GR, Yoneda T (2000) Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3–F442A. J Bone Miner Metab 18:132–139. doi:10.1007/s007740050103

    Article  CAS  PubMed  Google Scholar 

  9. Lorts A, Schwanekamp JA, Elrod JW, Sargent MA, Molkentin JD (2009) Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair. Circ Res 104:e1–e7. doi:10.1161/CIRCRESAHA.108.188649

    Article  CAS  PubMed  Google Scholar 

  10. Sasaki BH, Sato Y, Kondo S, Fukai I, Kiriyama M, Yamakawa Y, Fuji Y (2002) Expression of the periostin mRNA Level in neuroblastoma. J Pediatr Surg 37:1293–1297. doi:10.1053/jpsu.2002.34985

    Article  PubMed  Google Scholar 

  11. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T et al (2004) Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24:3992–4003. doi:10.1128/MCB.24.9.3992-4003.2004

    Article  CAS  PubMed  Google Scholar 

  12. Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu M (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5:329–339. doi:10.1016/S1535-6108(04)00081-9

    Article  CAS  PubMed  Google Scholar 

  13. Chang Y, Lee TC, Li JC, Lai TL, Chua HH, Chen CL et al (2005) Differential expression of osteoblast-specific factor 2 and polymeric immunoglobulin receptor genes in nasopharyngeal carcinoma. Head Neck 27:873–882. doi:10.1002/hed.20253

    Article  PubMed  Google Scholar 

  14. Kudo Y, Ogawa I, Kitajima S, Kitagawa M, Kawai H, Gaffney PM, Miyauchi M, Takata T (2006) Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66:6928–6935

    Article  CAS  PubMed  Google Scholar 

  15. Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T et al (2007) Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3 k pathway. Oncogene 26:2082–2094. doi:10.1038/sj.onc.1210009

    Article  CAS  PubMed  Google Scholar 

  16. Sasaki H, Auclair D, Fukai I, Kiriyama M, Yamakawa Y, Fuji Y et al (2001) Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92:843–848. doi:10.1002/1097-0142(20010815)92:4<843::AID-CNCR1391>3.0.CO;2-P

    Article  CAS  PubMed  Google Scholar 

  17. Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279. doi:10.1016/j.cell.2004.07.011

    Article  CAS  PubMed  Google Scholar 

  18. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341–350. doi:10.1172/JCI15518

    CAS  PubMed  Google Scholar 

  19. Greenburg G, Hay ED (1982) Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95:333–339

    Article  CAS  PubMed  Google Scholar 

  20. Yilmaz M, Christofori G, Lehembre F (2007) Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 13:535–541. doi:10.1016/j.molmed.2007.10.004

    Article  CAS  PubMed  Google Scholar 

  21. Blanco D, Vicent S, Elizegi E, Pino I, Fraga MF, Esteller M, Saffiotti U, Lecanda F, Montuenga LM (2004) Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest 84:999–1012. doi:10.1038/labinvest.3700129

    Article  CAS  PubMed  Google Scholar 

  22. Moch H, Schraml P, Bubendorf L, Mirlacher M, Konnen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G (1999) High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154:981–986

    CAS  PubMed  Google Scholar 

  23. Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man M, Ikeda JI et al (2007) Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer 96:986–992. doi:10.1038/sj.bjc.6603651

    Article  CAS  PubMed  Google Scholar 

  24. Chen JH, Lin HH, Chiang TA, Ho HH, Lee YC, Wang CJ (2008) Gaseous nitrogen oxide promotes human lung cancer cell line A549 migration, invasion, and metastasis via iNOS-mediated MMP-2 production. Toxicol Sci 106:364–375. doi:10.1093/toxsci/kfn195

    Article  CAS  PubMed  Google Scholar 

  25. Sasaki H, Yu CY, Dai M, Tam C, Loda M, Auclair D, Chen LB, Elias A (2003) Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat 77:245–252. doi:10.1023/A:1021899904332

    Article  CAS  PubMed  Google Scholar 

  26. Soltermann A, Tischler V, Arbogast S, Braun J, Hensch NP, Weder W, Moch H, Kristiansen G (2008) Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14:7430–7437. doi:10.1158/1078-0432

    Article  CAS  PubMed  Google Scholar 

  27. Ouyang G, Liu M, Ruan K, Song G, Mao Y, Bao S (2009) Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett 281:213–219. doi:10.1016/j.canlet.2009.02.030

    Google Scholar 

  28. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142. doi:10.1038/nrm1835

    Article  CAS  PubMed  Google Scholar 

  29. Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, Fu L et al (2005) Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 11:8686–8698

    Article  CAS  PubMed  Google Scholar 

  30. Bremnes RM, Veve R, Hirsch FR, Franklin WA (2002) The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36:115–124. doi:10.1016/S0169-5002(01)00471-8

    Article  PubMed  Google Scholar 

  31. Liu WF, Nelson CM, Pirone DM, Chen CS (2006) E-cadherin engagement stimulates proliferation via Rac1. J Cell Biol 173:431–441. doi:10.1083/jcb.200510087

    Article  CAS  PubMed  Google Scholar 

  32. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G et al (1995) Structural basis of cell-cell adhesion by cadherins. Nature 374:327–337. doi:10.1038/374327a0

    Article  CAS  PubMed  Google Scholar 

  33. Gumbiner BM (2000) Regulation of cadherin adhesive activity. J Cell Biol 148:399–404

    Article  CAS  PubMed  Google Scholar 

  34. Hatsell S, Rowlands T, Hiremath M, Cowin P (2003) Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8:145–158. doi:10.1023/A:1025944723047

    Article  PubMed  Google Scholar 

  35. Doherty P, Walsh FS (1996) CAM-FGF receptor interactions: a model for axonal growth. Mol Cell Neurosci 8:99–111. doi:10.1006/mcne.1996.0049

    Article  CAS  Google Scholar 

  36. Watabe M, Nagafuchi A, Tsukita S, Takeichi M (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127:247–256

    Article  CAS  PubMed  Google Scholar 

  37. Kandikonda S, Oda D, Niederman R, Sorkin BC (1996) Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells. Cell Adhes Commun 4:13–24

    Article  CAS  PubMed  Google Scholar 

  38. Croix BS, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS (1998) E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol 142:557–571

    Article  Google Scholar 

  39. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118–132

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by High-Tech Platform for Molecular Diagnosis and Biological Therapy of Critical Illness (XK200507) and Study on Inhibit Action of NSCLC by Exogenous Expression of Let-7 (BK2008326).

Author information

Authors and Affiliations

  1. Department of Respiratory Diseases, Jinling Hospital, School of Medicine, Nanjing University, 210002, Nanjing, Jiangsu Province, People’s Republic of China

    Lingzhi Hong, Huiming Sun, Xiaojing Lv & Yi Shi

  2. Institute of Cardiology, First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, Jiangsu Province, People’s Republic of China

    Di Yang & Jinan Zhang

Authors
  1. Lingzhi Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huiming Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaojing Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Di Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jinan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Shi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hong, L., Sun, H., Lv, X. et al. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep 37, 2285–2293 (2010). https://doi.org/10.1007/s11033-009-9721-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9721-1

Keywords

Search

Navigation